Search Results for 'hiv cell'

hiv cell published presentations and documents on DocSlides.

 Cell/gene therapy  HIV Cure Research Training Curriculum
Cell/gene therapy HIV Cure Research Training Curriculum
by test
Cell/Gene Therapy by: . Jeff Sheehy, the Californ...
Cell/gene therapy  HIV Cure Research Training Curriculum
Cell/gene therapy HIV Cure Research Training Curriculum
by tawny-fly
Cell/Gene Therapy by: . Jeff Sheehy, the Californ...
Chapter 15: HIV and AIDS
Chapter 15: HIV and AIDS
by jalin
Biology Trending, 4e. Eli Minkoff and Jennifer Hoo...
NIH Workshop on HIV-Associated Comorbidities, Coinfections and Complications:
NIH Workshop on HIV-Associated Comorbidities, Coinfections and Complications:
by elena
Aging and Senescence . Judith . Campisi. Ph.D.: T...
 The HIV Epidemic:  Biology of the virus and modes of therapy
The HIV Epidemic: Biology of the virus and modes of therapy
by min-jolicoeur
OVERVIEW. Key Take-Home Ideas. History of the vi...
2014 “Towards an HIV Cure”
2014 “Towards an HIV Cure”
by danika-pritchard
Symposium. Melbourne. IL-21 . reduces . residual ...
Molecular characteristics of HIV-2
Molecular characteristics of HIV-2
by danika-pritchard
Frank Kirchhoff . Institute of . Molecular. . Vi...
The basics of HIV Cure Research
The basics of HIV Cure Research
by tatiana-dople
HIV . Cure Research Training Curriculum. HIV and ...
Inflammation biomarkers in HIV infection
Inflammation biomarkers in HIV infection
by danika-pritchard
Laurence WEISS. Predictive biomarkers in HIV infe...
Vesatolimod (GS-9620) Is Safe and Pharmacodynamically Active in HIV-Infected Individuals
Vesatolimod (GS-9620) Is Safe and Pharmacodynamically Active in HIV-Infected Individuals
by genevieve
Sharon A. Riddler. 1. , Michael Para. 2. , Constan...
ANTI-HIV AND ANTICANCER DRUG
ANTI-HIV AND ANTICANCER DRUG
by roy
DEPARTMENT OF CHEMISTRY. D.D.U. GORAKHPUR UNIVERSI...
HIV in Flux Viruses We’re talking tiny: 110 – 150 nm
HIV in Flux Viruses We’re talking tiny: 110 – 150 nm
by TacoBellDiego
That’s 150 billionths of a meter. The bad guy . ...
Vaccine Prevention for Adults With HIV in the Era of COVID-19
Vaccine Prevention for Adults With HIV in the Era of COVID-19
by ThePerfectFit
David H. Spach, MD. Professor of Medicine, Divisio...
Medical Management of Persons Living with HIV
Medical Management of Persons Living with HIV
by DontBeASnitch
2022 MCO Training. Michelle Agnoli, RN, MSN. Clini...
Mechanisms of HIV-1  Resistance to ADCC
Mechanisms of HIV-1 Resistance to ADCC
by isla
David Evans. University of Wisconsin-Madison. July...
HIV/AIIDS & Mucosal Vaccines
HIV/AIIDS & Mucosal Vaccines
by skylar
Charani Ranasinghe. Molecular Mucosal Vaccine Immu...
HIV and other retroviral diseases (related oral infections) in Afro-Asian countries
HIV and other retroviral diseases (related oral infections) in Afro-Asian countries
by roxanne
Dr. Cathy Nisha John. University of the Western C...
Progress in the HIV Vaccine Field
Progress in the HIV Vaccine Field
by eatsui
Larry Corey, MD. Principal Investigator, NIAID sup...
Measuring the latent HIV Reservoir
Measuring the latent HIV Reservoir
by cheryl-pisano
Measuring the latent HIV Reservoir HIV Cure Resea...
State of the ART:  HIV  Cure –
State of the ART: HIV Cure –
by conchita-marotz
where . are we now and . where . are we going? . ...
HIV/AIDS Human Immunodeficiency Virus
HIV/AIDS Human Immunodeficiency Virus
by lindy-dunigan
Acquired Immune Deficiency Syndrome. HIV/AIDS. HI...
HIV/AIDS Human Immunodeficiency Virus
HIV/AIDS Human Immunodeficiency Virus
by alida-meadow
Acquired Immune Deficiency Syndrome. HIV/AIDS. HI...
HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1
HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1
by danika-pritchard
, HIV-2. ). . Introduction. HIV is a sexually tr...
Pof . Ivo Ivić HIV  infection
Pof . Ivo Ivić HIV infection
by lois-ondreau
Epidemiology. . Croatia. -. 1300 . persons. . w...
HIV/AIDS 2014 Basic Definitions
HIV/AIDS 2014 Basic Definitions
by alexa-scheidler
AIDS – Acquired Immunodeficiency Syndrome. Fina...
Advances and Challenges in HIV Antiretroviral Therapy
Advances and Challenges in HIV Antiretroviral Therapy
by stefany-barnette
Camille Angle, Meagan Bardan, Hanna Schimjawicz a...
Antiretroviral Agents: HIV & AIDS
Antiretroviral Agents: HIV & AIDS
by min-jolicoeur
Shaw Vonder Hoya. Worldwide Prevalence. Types of ...
HIV/AIDS Human Immunodeficiency Virus
HIV/AIDS Human Immunodeficiency Virus
by ellena-manuel
Acquired Immune Deficiency Syndrome. HIV/AIDS. HI...
HIV Organ Policy Equity (HOPE) Act
HIV Organ Policy Equity (HOPE) Act
by aaron
Research Criteria: follow-up discussion. . ...
Experimental Medicine Trials of Promising HIV Candidates
Experimental Medicine Trials of Promising HIV Candidates
by phoebe-click
Robin Shattock. . Experimental . Medicine . Tria...
HIV susceptibility and CCR5
HIV susceptibility and CCR5
by karlyn-bohler
Anna-Lisa Doebley . Final Presentation. May 6. th...
Elimination of HIV-1 latently infected cells by PKC agonist
Elimination of HIV-1 latently infected cells by PKC agonist
by pamella-moone
gnidimacrin. alone and in combination with an HD...
HIV and Non Hodgkin Lymphoma
HIV and Non Hodgkin Lymphoma
by karlyn-bohler
Virginia C. . Broudy. , MD. September 25, 2014. P...
Immune Responses to HIV
Immune Responses to HIV
by alexa-scheidler
Zoran . Galic. Ph.D. .. Division of Hematology/O...
Third generation long-read sequencing of HIV-1 transcripts
Third generation long-read sequencing of HIV-1 transcripts
by phoebe-click
Frederic Bushman. International AIDS Meeting. Was...